참고문헌
- Hoy MD, O'Donnell JL, Hart DN: Dual CD45RA, CD45RO positive T-lymphocytes within rheumatoid arthritic joints. Pathology 25;167-173, 1993 https://doi.org/10.3109/00313029309084793
- Mittal GA, Joshi VR, Deshpande A: Stromal cell-derived factor-1 alpha in rheumatoid arthritis. Rheumatology (Oxford) 42;915-916, 2003 https://doi.org/10.1093/rheumatology/keg234
- Kanbe K, Takagishi K, Chen Q: Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum 46;130-137, 2002 https://doi.org/10.1002/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D
- Grassi F, Cristino S, Toneguzzi S, Piacentini A, Facchini A, Lisignoli G: CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J Cell Physiol 199;244-251, 2004 https://doi.org/10.1002/jcp.10445
- Pablos JL, Santiago B, Galindo M, Torres C, Brehmer MT, Blanco FJ, Garcia-Lazaro FJ: Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 170;2147-2152, 2003 https://doi.org/10.4049/jimmunol.170.4.2147
- Blades MC, Ingegnoli F, Wheller SK, Manzo A, Wahid S, Panayi GS, Perretti M, Pitzalis C: Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice. Arthritis Rheum 46;824-836, 2002 https://doi.org/10.1002/art.10102
- De Klerck B, Geboes L, Hatse S, Kelchtermans H, Meyvis Y, Vermeire K, Bridger G, Billiau A, Schols D, Matthys P: Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis. Arthritis Res Ther 7;R1208-R1220, 2005 https://doi.org/10.1186/ar1806
- Tamamura H, Fujisawa M, Hiramatsu K, Mizumoto M, Nakashima H, Yamamoto N, Otaka A, Fujii N: Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent. FEBS Lett 569;99-104, 2004 https://doi.org/10.1016/j.febslet.2004.05.056
- Hitchon C, Wong K, Ma G, Reed J, Lyttle D, El-Gabalawy H: Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 46;2587-2597, 2002 https://doi.org/10.1002/art.10520
- David JR: Delayed hypersensitivity in vitro: its mediation by cell free substances formed by lymphoid cell-antigen interaction. Pathology 56;72-77, 1966
- Nathan CF, Karnovsky ML, David JR: Alterations of macrophage functions by mediator from lymphocytes. J Exp Med 133;1356-1376, 1971 https://doi.org/10.1084/jem.133.6.1356
- Bloom BR, Bennet B: Mechanism of a reaction in vitro associated with delayed hypersensitivity. Science 153;80-82, 1966 https://doi.org/10.1126/science.153.3731.80
- Shimizu T, Ohkawara A, Nishihira J, Sakamoto W: Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS Lett 381;199-202, 1996 https://doi.org/10.1016/0014-5793(96)00120-2
- Matsuda A, Tagawa Y, Matsuda H, Nishihira J: Identification and immunohistochemical localization of macrophage migration inhibitory factor in human cornea. FEBS Lett 385;225-228, 1996 https://doi.org/10.1016/0014-5793(96)00386-9
- Onodera S, Suzuki K, Matsuno T, Kaneda K, Kuriyama T, Nishihira J: Identification of macrophage migration inhibitory factor in murine neonatal calvariae and osteoblasts. Immunology 89;430-435, 1996 https://doi.org/10.1046/j.1365-2567.1996.d01-751.x
- Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R: An essential regulatory role for macrophage migration inhibitor factor in T-cell activation. Proc Natl Acad Sci USA 93;7849-7854, 1996
- Lolis E: Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery. Curr Opin Pharmacol 1;662-668, 2001 https://doi.org/10.1016/S1471-4892(01)00112-6
- Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donelly T, Cerami A, Cucala R: MIF as a glucocorticoidinduced modulator of cytokine production. Nature 377;68-71, 1995 https://doi.org/10.1038/377068a0
- Morand EF, Bucala R, Leech M: Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. Arthritis Rheum 48;291-299, 2003 https://doi.org/10.1002/art.10728
- Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth SR, Bucala R, Morand EF: Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 42;1601-1608, 1999 https://doi.org/10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B
- Morand EF, Leech M, Weedon H, Metz C, Bucala R, Smith MD: Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology 41;558-562, 2002 https://doi.org/10.1093/rheumatology/41.5.558
- Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, Morand E: Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 48;103-109, 2003 https://doi.org/10.1002/art.10733
- Selvi E, Tripodi SA, Catenaccio M, Lorenzini S, Chindamo D, Manganelli S, Romaqnoli R, Letta F, Paulesu L, Miracco C, Cintorino M, Marcolonqo R: Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis. Ann Rheum Dis 62;460-464, 2003 https://doi.org/10.1136/ard.62.5.460
- Meazza C, Travaglino P, Pignatti P, Magni-Manzoni S, Ravelli A, Martini A, De Benedetti F: Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum 46;232-237, 2002 https://doi.org/10.1002/1529-0131(200201)46:1<232::AID-ART10059>3.0.CO;2-B
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Linanq MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31;315-324, 1988 https://doi.org/10.1002/art.1780310302
- Kim KW, Cho ML, Kim HR, Ju JH, Park MK, Oh HJ, Kim JS, Park SH, Lee SH, Kim HY: Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: Role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum 56;1076-1086 2007 https://doi.org/10.1002/art.22439
- Goronzy JJ, Weyand CM: Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol 22;251-255, 2001 https://doi.org/10.1016/S1471-4906(00)01841-X
- Weyand CM, Goronzy JJ: T-cell responses in rheumatoid arthritis: systemic abnormalities-local disease. Curr Opin Rheumatol 11;210-217, 1999 https://doi.org/10.1097/00002281-199905000-00010
- Aarvak T, Narvig JB: Cell-cell interactions in synovitis: antigen presenting cells and T cell interaction in rheumatoid arthritis. Arthritis Res 3;13-317, 2001 https://doi.org/10.1186/ar135
- Mbemba E, Benjouad A, Saffar L, Gattegno L: Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells. Virology 265;354-364, 1999 https://doi.org/10.1006/viro.1999.0033
- Burger JA, Kipps TJ: CXCR4: A key receptor in the cross talk between tumor cells and their microenvironment. Blood 107;1761-1767, 2006 https://doi.org/10.1182/blood-2005-08-3182
- Dubois-Laforgue D, Hendel H, Caillat-Zucman S, Zagury JF, Winkler C, Boitard C, Timsit J: A common stromal cellderived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 50;1211-1213, 2001 https://doi.org/10.2337/diabetes.50.5.1211
-
Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, Girschick HJ, Yavuz S, Lipsky PE: Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in
$CD4^{+}$ T cell accumulation in rheumatoid arthritis synovium. J Immunol 165;6590-6598, 2000 https://doi.org/10.4049/jimmunol.165.11.6590 - Hitchon C, Wong K, Ma G, Reed J, Lyttle D, El-Gabalawy H: Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 46;2587-2597, 2002 https://doi.org/10.1002/art.10520
- Fedyk ER, Jones D, Critchley HO, Phipps RP, Blieden TM, Springer TA: Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J Immunol 166;5749-5754, 2001 https://doi.org/10.4049/jimmunol.166.9.5749
- Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, Honjo T: Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28;495-500, 1995 https://doi.org/10.1006/geno.1995.1180
- Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH, Cho CS, Kim HY: Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 19;321-324, 2001
- Cho ML, Cho CS, Min SY, Kim SH, Lee SS, Kim WU, Min DJ, Min JK, Youn J, Hwang SY, Park SH, Kim HY: Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Arthritis Rheum 46;1202-1209, 2002 https://doi.org/10.1002/art.10215
- Munaut C, Boniver J, Foidart JM Deprez M: Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression. Neuropathol Appl Neurobiol 28;452-460, 2002 https://doi.org/10.1046/j.1365-2990.2002.00416.x
- Radstake TR, Sweep FC, Welsing P Franke B, Vermeulen SH, Geurts-Moespot A, Calandra T, Donn R, van Riel PL: Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 52;3020-3029, 2005 https://doi.org/10.1002/art.21285
- Ren Y, Law S, Huang X, Lee PY, Bacher M, Srivastava G, Wonq J: Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg 242;55-63, 2005 https://doi.org/10.1097/01.sla.0000168555.97710.bb
- Ren Y, Tsui HT, Poon RT, Nq IO, Li Z, Chen Y, Jianq G, Lau C, Yu WC, Bacher M, Fan ST: Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int J Cancer 107;22-29, 2003 https://doi.org/10.1002/ijc.11287
-
Chen X, Beutler JA, McCloud TG, Loehfelm A, Yang L, Dong HF, Chertov OY, Salcedo R, Oppenheim JJ, Howard OM: Tannic Acid Is an Inhibitor of CXCL12 (SDF-
$\alpha$ )/CXCR4 with Antiangiogenic Activity. Clin Cancer Res 9;3115-3123, 2003 - Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ: CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35;233-245, 2004 https://doi.org/10.1023/B:HIJO.0000032355.66152.b8